Unknown

Dataset Information

0

Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.

ABSTRACT: [Figure: see text].

SUBMITTER: Chan You S 

PROVIDER: S-EPMC8035236 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients: A Large-Scale Multicenter Observational Study.

Chan You Seng S   Krumholz Harlan M HM   Suchard Marc A MA   Schuemie Martijn J MJ   Hripcsak George G   Chen RuiJun R   Shea Steven S   Duke Jon J   Pratt Nicole N   Reich Christian G CG   Madigan David D   Ryan Patrick B PB   Woong Park Rae R   Park Sungha S  

Hypertension (Dallas, Tex. : 1979) 20210329 5

[Figure: see text]. ...[more]

Similar Datasets

Unknown Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
| S-EPMC6924620 | biostudies-literature
Unknown A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy.
| S-EPMC7485356 | biostudies-literature
Unknown Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study.
| S-EPMC12686790 | biostudies-literature
Unknown Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
| S-EPMC8907842 | biostudies-literature
Unknown First-Line β-Blocker Use for Hypertension in the Veterans Health Administration.
| S-EPMC12391979 | biostudies-literature
Unknown P2Y12 blocker monotherapy after percutaneous coronary intervention.
| S-EPMC8556441 | biostudies-literature
Unknown First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine.
| S-EPMC7850548 | biostudies-literature
Unknown Patient-Reported Outcomes With First-Line Immunotherapy-Based Combination Treatment for Advanced Lung Cancer: A Prospective, Multicenter, Observational Study.
| S-EPMC12445973 | biostudies-literature
Unknown Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
| S-EPMC5569692 | biostudies-literature
Unknown Cost-effectiveness analysis of first-line gifitinib plus pemetrexed-platinum-based chemotherapy versus gifitinib monotherapy in EGFR-mutated NSCLC patients with brain metastases
| S-EPMC12382008 | biostudies-literature